Nondisposable materials, chronic inflammation, and adjuvant action

Journal of Leukocyte Biology

Volumn 73, Issue 6, 2003, Pages 702-712

  Hamilton, John A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alum; CSF 1; M CSF; Macrophage survival; Oxidized LDL

Indexed keywords

ADJUVANT; ALUMINUM; ALUMINUM POTASSIUM SULFATE; AMYLOID; ANTIGEN; BIOMATERIAL; BOVINE SERUM ALBUMIN; CALCIUM PHOSPHATE; CALCIUM PYROPHOSPHATE; COLONY STIMULATING FACTOR 1; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT; LOW DENSITY LIPOPROTEIN; OIL; OLIGONUCLEOTIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEPTIDE; PRION PROTEIN; SILICON DIOXIDE; TALC; URATE; WATER;

ALZHEIMER DISEASE; APOPTOSIS; ATHEROSCLEROTIC PLAQUE; BACTERIUM; CELL ACTIVATION; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC INFLAMMATION; CONCENTRATION (PARAMETERS); CRYSTAL; DEGENERATIVE DISEASE; DNA SYNTHESIS; EMULSION; FOAM CELL; HEMATOPOIETIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; IMPLANT; IN VIVO STUDY; JOINT; MACROPHAGE; MATERIALS; MICROGLIA; MICROORGANISM; MOLECULAR BIOLOGY; NONHUMAN; PARTICULATE MATTER; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; REGULATORY MECHANISM; REVIEW; ANIMAL; ARTERIOSCLEROSIS; CELL DIVISION; CHRONIC DISEASE; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); BOVINAE;

ADJUVANTS, IMMUNOLOGIC; AMYLOID; ANIMALS; ARTERIOSCLEROSIS; CELL DIVISION; CELL SURVIVAL; CHRONIC DISEASE; FOAM CELLS; INFLAMMATION; LIPOPROTEINS, LDL; MACROPHAGES; NEURODEGENERATIVE DISEASES;

EID: 0037666212     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0103037     Document Type: Review

References (122)

1. Rosenfeld, M. E., Ross, R. (1990) Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 10, 680-687.
2. Gordon, D., Reidy, M. A., Benditt, E. P., Schwartz, S. M. (1990) Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. USA 87, 4600-4604.
3. Spagnoli, L. G., Orlandi, A., Santeusanio, G. (1991) Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by colchicine show a macrophage phenotype. Atherosclerosis 88, 87-92.
4. Jutila, M. A., Banks, K. L. (1988) Increased macrophage division in the synovial fluid of goats infected with caprine arthritis-encephalitis virus. J. Infect. Dis. 157, 1193-1202.
5. Yamada, M., Naito, M., Takahashi, K. (1990) Kupffer cell proliferation and glucan-induced granuloma formation in mice depleted of blood monocytes by strontium-89. J. Leukoc. Biol. 47, 195-205.
6. Metcalf, D. (1989) The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339, 27-30.
7. Greenhalgh, D. G. (1998) The role of apoptosis in wound healing. Int. J. Biochem. Cell Biol. 30, 1019-1030.
8. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
9. Ross, R. (1993) The pathogenesis of atheroslerosis: a perspective for the 1990s. Nature 362, 801-809.
10. Pasceri, V., Yeh, E. T. (1999) A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100, 2124-2126.
11. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., Witztum, J. L. (1989) Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915-924.
12. Villaschi, S., Spagnoli, L. G. (1983) Autoradiographic and ultrastructural studies on the human fibro- atheromatous plaque. Atherosclerosis 48, 95-100.
13. Katsuda, S., Coltrea, M. D., Ross, R., Gown, A. M. (1993) Human atherosclerosis IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am. J. Pathol. 142, 1787-1792.
14. Rekhter, M. D., Gordon, D. (1995) Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am. J. Pathol. 147, 668-677.
15. Wang, J., Wang, S., Lu, Y., Weng, Y., Gown, A. M. (1994) GM-CSF and M-CSF expression is associated with macrophage proliferation in progressing and regressing rabbit atheromatous lesions. Exp. Mol. Pathol. 61, 109-118.
16. Yui, S., Sasaki, T., Miyazaki, A., Horiuchi, S., Yamazaki, M. (1993) Induction of murine macrophage growth by modified LDLs. Arterioscler. Thromb. 13, 331-337.
17. Martens, J. S., Reiner, N. E., Herrera-Velit, P., Steinbrecher, U. P. (1998) Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein. J. Biol. Chem. 273, 4915-4920.
18. Hamilton, J. A., Myers, D., Jessup, W., Cochrane, F., Byrne, R., Whitty, G., Moss, S. (1999) Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler. Thromb. Vasc. Biol. 19, 98-105.
19. Hamilton, J. A., Whitty, G., Jessup, W. (2000) Oxidized LDL can promote human monocyte survival. Arterioscler. Thromb. Vasc. Biol. 20, 2329-2331.
20. Hamilton, J. A., Byrne, R., Jessup, W., Kanagasundaram, V., Whitty, G. (2001) Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1). Biochem. J. 354, 179-187.
21. Hamilton, J. A., Jessup, W., Brown, A. J., Whitty, G. (2001) Enhancement of macrophage survival and DNA synthesis by oxidized-low-density-lipoprotein (LDL)-derived lipids and by aggregates of lightly oxidized LDL. Biochem. J. 355, 207-214.
22. Reid, V. C., Mitchinson, M. J., Skepper, J. N. (1993) Cytotoxicity of oxidized low-density lipoprotein to mouse peritoneal macrophages: an ultrastructural study. J. Pathol. 171, 321-328.
23. Hardwick, S. J., Hegyi, L., Clare, K., Law, N. S., Carpenter, K. L., Mitchinson, M. J., Skepper, J. N. (1996) Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein. J. Pathol. 179, 294-302.
24. Hoppe, G., O'Neil, J., Hoff, H. F. (1994) Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages. J. Clin. Invest. 94, 1506-1512.
25. Lougheed, M., Zhang, H. F., Steinbrecher, U. P. (1991) Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. J. Biol. Chem. 266, 14519-14525.
26. Roma, P., Bernini, F., Foglialto, R., Bertulli, S. M., Negri, S., Fumagalli, R., Catapano, A. L. (1992) Defective catabolism of oxidized LDL by J774 murine macrophages. J. Lipid Res. 33, 819-829.
27. Dhaliwal, B. S., Steinbrecher, U. P. (2000) Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally. J. Lipid Res. 41, 1658-1665.
28. Jessup, W., Kritharides, L. (2000) Metabolism of oxidized LDL by macrophages. Curr. Opin. Lipidol. 11, 473-481.
29. Tertov, V. V., Orekhov, A. N., Sobenin, I. A., Gabbasov, Z. A., Popov, E. G., Yaroslavov, A. A., Smirnov, V. N. (1992) Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ. Res. 71, 218-228.
30. Hoff, H. F., Zyromski, N., Armstrong, D., O'Neil, J. (1993) Aggregation as well as chemical modification of LDL during oxidation is responsible for poor processing in macrophages. J. Lipid Res. 34, 1919-1929.
31. Steinbrecher, U. P., Lougheed, M. (1992) Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler. Thromb. 12, 608-625.
32. Hamilton, J. A. (1993) Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet 342, 536-539.
33. Hamilton, J. A. (2002) GM-CSF in inflammation and autoimmunity. Trends Immunol. 23, 403-408.
34. Bartocci, A., Pollard, J. W., Stanley, E. R. (1986) Regulation of colony-stimulating factor 1 during pregnancy. J. Exp. Med. 164, 956-961.
35. Cecchini, M. G., Dominguez, M. G., Mocci, S., Wellerwald, A., Felix, R., Fleisch, H., Chisholm, O., Hofstetter, W., Pollard, J. W., Stanley, E. R. (1994) Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120, 1357-1372.
36. Rosenfeld, M. E., Yla-Herttuala, S., Lipton, B. A., Ord, V. A., Witztum, J. L., Steinberg, D. (1992) Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am. J. Pathol. 140, 291-300.
37. Salomon, R. N., Underwood, R., Doyle, M. V., Wang, A., Libby, P. (1992) Increased apolipoprotein E and c-fins gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc. Natl. Acad. Sci. USA 89, 2814-2818.
38. Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., Lusis, A. J. (1990) Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344, 254-257.
39. Sieff, C. A., Niemeyer, C. M., Mentzer, S. J., Faller, D. V. (1988) Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells. Blood 72, 1316-1323.
40. Schrader, J. W., Moyer, C., Ziltener, H. J., Reinisch, C. L. (1991) Release of the cytokines colony-stimulating factor-1, granulocyte-macrophage colony-stimulating factor, and IL-6 by cloned murine vascular smooth muscle cells. J. Immunol. 146, 3799-3808.
41. Filonzi, E. L., Zoellner, H., Stanton, H., Hamilton, J. A. (1993) Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cells. Atherosclerosis 99, 241-252.
42. de Villiers, W. J., Fraser, I. P., Hughes, D. A., Doyle, A. G., Gordon, S. (1994) Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J. Exp. Med. 180, 705-709.
43. Tushinski, R. J., Oliver, I. T., Guilbert, L. J., Tynan, P. W., Warner, I.R., Stanley, E. R. (1982) Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28, 71-81.
44. Hamilton, J. A., Byrne, R., Whitty, G. (2000) Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1. J. Leukoc. Biol. 67, 226-232.
45. Hamilton, J. A., McCarthy, G., Whitty, G. (2001) Inflammatory microcrystals induce murine macrophage survival and DNA synthesis. Arthritis Res. 3, 242-246.
46. Hamilton, J. A., Whitty, G., White, A. R., Jobling, M. F., Thompson, A., Barrow, C. J., Cappai, R., Beyreuther, K., Masters, C. L. (2002) Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF). Brain Res. 940, 49-54.
47. Sakai, M., Miyazaki, A., Hakamata, H., Sasaki, T., Yui, S., Yamazaki, M., Shichiri, M., Horiuchi, S. (1994) Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J. Biol. Chem. 269, 31430-31435.
48. Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., Protter, A. A. (1993) CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268, 11811-11816.
49. Stanton, L. W., White, R. T., Bryant, C. M., Protter, A. A., Endemann, G. (1992) A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267, 22446-22451.
50. Sawamura, T., Kume, N., Aoyama, T., Moriwaki, H., Hoshikawa, H., Aiba, Y., Tanaka, T., Miwa, S., Katsura, Y., Kita, T., Masaki, T. (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386, 73-77.
51. Acton, S. L., Scherer, P. E., Lodish, H. F., Krieger, M. (1994) Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269, 21003-21009.
52. Ramprasad, M. P., Fischer, W., Witztum, J. L., Sambrano, G. R., Quehenberger, O., Steinberg, D. (1995) The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc. Natl. Acad. Sci. USA 92, 9580-9584.
53. Tontonoz, P., Nagy, L., Alvarez, J. G., Thomazy, V. A., Evans, R. M. (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252.
54. Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., Glass, C. K. (2000) Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 106, 523-531.
55. Rosen, E. D., Spiegelman, B. M. (2000) Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache. J. Clin. Invest. 106, 629-631.
56. Biwa, T., Hakamata, H., Sakai, M., Miyazaki, A., Suzuki, H., Kodama, T., Shichiri, M., Horiuchi, S. (1998) Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor. J. Biol. Chem. 273, 28305-28313.
57. Biwa, T., Sakai, M., Matsumura, T., Kobori, S., Kaneko, K., Miyazaki, A., Hakamata, H., Horiuchi, S., Shichiri, M. (2000) Sites of action of protein kinase C and phosphatidylinositol 3-kinase are distinct in oxidized low density lipoprotein-induced macrophage proliferation. J. Biol. Chem. 275, 5810-5816.
58. Matsumura, T., Sakai, M., Matsuda, K., Furukawa, N., Kaneko, K., Shichiri, M. (1999) Cis-acting DNA elements of mouse granulocyte/macrophage colony-stimulating factor gene responsive to oxidized low density lipoprotein. J. Biol. Chem. 274, 37665-37672.
59. Sakai, M., Biwa, T., Matsumura, T., Takemura, T., Matsuda H., Anami, Y., Sasahara, T., Kobori, S., Shichiri, M. (1999) Glucocorticoid inhibits oxidized LDL-induced macrophage growth by suppressing the expression of granulocyte/macrophage colony-stimulating factor. Arterioscler. Thromb. Vasc. Biol. 19, 1726-1733.
60. Hundal, R. S., Salh, B. S., Schrader, J. W., Gomez-Munoz, A., Duronio, V., Steinbrecher, U. P. (2001) Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J. Lipid Res. 42, 1483-1491.
61. Matsumura, T., Sakai, M., Kobori, S., Biwa, T., Takemura, T., Matsuda, H., Hakamata, H., Horiuchi, S., Shichiri, M. (1997) Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growth. Arterioscler. Thromb. Vasc. Biol. 17, 3013-3020.
62. Schackelford, R. E., Misra, U. K., Florine-Casteel, K., Thai, S. F., Pizzo, S. V., Adams, D. O. (1995) Oxidized low density lipoprotein suppresses activation of NF kappa B in macrophages via a pertussis toxin-sensitive signaling mechanism. J. Biol. Chem. 270, 3475-3478.
63. Shiffman, D., Mikita, T., Tai, J. T., Wade, D. P., Porter, J. G., Seilhamer, J. J., Somogyi, R., Liang, S., Lawn, R. M. (2000) Large scale gene expression analysis of cholesterol-loaded macrophages. J. Biol. Chem. 275, 37324-37332.
64. Wegiel, J., Wisniewski, H. M. (1990) The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol. (Berl.) 81, 116-124.
65. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA. 95, 13363-13383.
66. Gonzalez-Scarano, F., Baltuch, G. (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22, 219-240.
67. Korotzer, A. R., Pike, C. J., Cotman, C. W. (1993) beta-Amyloid peptides induce degeneration of cultured rat microglia. Brain Res. 624, 121-125.
68. McHattie, S. J., Brown, D. R., Bird, M. M. (1999) Cellular uptake of the prion protein fragment PrP106-126 in vitro. J. Neurocytol. 28, 149-159.
69. Paresce, D. M., Chung, H., Maxfield, F. R. (1997) Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J. Biol. Chem. 272, 29390-29397.
70. Paresce, D. M., Ghosh, R. N., Maxfield, F. R. (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17, 553-565.
71. De Meyer, G. R., De Cleen, D. M., Cooper, S., Knaapen, M. W., Jans D. M., Martinet, W., Herman, A. G., Bult, H., Kockx, M. M. (2002) Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ. Res. 90, 1197-1204.
72. El Khoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., Loike, J. D. (1996) Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382, 716-719.
73. Moore, K. J., El Khoury, J., Medeiros, L. A., Terada, K., Geula, C., Luster, A. D., Freeman, M. W. (2002) A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 277, 47373-47379.
74. Araujo, D. M., Cotman, C. W. (1992) Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569, 141-145.
75. Brown, D. R., Schmidt, B., Kretzschmar, H. A. (1996) A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia 18, 59-67.
76. Akiyama, H., Nishimura, T., Kondo, H., Ikeda, K., Hayashi, Y., McGeer, P. L. (1994) Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis. Brain Res. 639, 171-174.
77. Du Yan, S., Zhu, H., Fu, J., Yan, S. F., Roher, Tourlellotte, W. W., Rajavashisth, T., Chen, X., Godman, G. C., Stern, D., Schmidt, A. M. (1997) Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 5296-5301.
78. DeArmond, S. J., Mobley, W. C., DeMott, D. L., Barry, R. A., Beckstead, J. H., Prusiner, S. B. (1987) Changes in the localization of brain prion proteins during scrapie infection. Neurology 37, 1271-1280.
79. Murphy, G. M., Yang, L., Cordell. B. (1998) Macrophage colony-stimulating factor augments b-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J. Biol. Chem. 273, 20967-20971.
80. Peyrin, J. M., Lasmezas, C. I., Haik, S., Tagliavini, F., Salmona, M., Williams, A., Richie, D., Deslys, J. P., Dormont, D. (1999) Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 10, 723-729.
81. Schumacher Jr., H. R. (1995) Synovial inflammation, crystals, and osteoarthritis. J. Rheumutol. Suppl. 43, 101-103.
82. Prudhommeaux, F., Schiltz, C., Liote, F., Hina, A., Champy, R., Bucki, B., Ortiz-Bravo, E., Meunier, A., Rey, C., Bardin, T. (1996) Variation in the inflammatory properties of basic calcium phosphate crystals according to crystal type. Arthritis Rheum. 39, 1319-1326.
83. Ryan, L., McCarty, D. (1997) Calcium pyrosphate crystal deposition disease, pseudogout and articular chondrocalcinosis. In Arthritis and Allied Conditions (W. Koopman, ed.), Baltimore, MD, Williams and Wilkins, 2013-2025.
84. Duff, G. W., Atkins, E., Malawista, S. E. (1983) The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. Trans. Assoc. Am. Physicians 96, 234-245.
85. Terkeltaub, R. A. (1999) Clinical trials review: crystal deposition diseases. Curr. Rheumatol. Rep. 1, 97-100.
86. di Giovine, F. S., Malawista, S. E., Thornton, E., Duff, G. W. (1991) Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J. Clin. Invest. 87, 1375-1381.
87. Landis, R. C., Yagnik, D. R., Florey, O., Philippidis, P., Emons, V., Mason, J. C., Haskard, D. O. (2002) Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum. 46, 3026-3033.
88. Sparrow, S. A., Hallam, L. A. (1991) Talc granulomas. BMJ 303, 58.
89. Donaldson, K. (2000) Nonneoplastic lung responses induced in experimental animals by exposure to poorly soluble nonfibrous particles. Inhal. Toxicol. 12, 121-139.
90. Cox, J. C., Coulter, A. R. (1997) Adjuvants-a classification and review of their modes of action. Vaccine 15, 248-256.
91. McWilliam, A. S., Napoli, S., Marsh, A. M., Pemper, F. L., Nelson, D. J., Pimm, C. L., Stumbles, P. A., Wells, T. N., Holt, P. G. (1996) Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 184, 2429-2432.
92. Sallusto, F., Lanzavecchia, A. (1999) Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189, 611-614.
93. Disis, M. L., Bernhard, H., Shiota, F. M., Hand, S. L., Gralow, J. R., Huseby, E. S., Gillis, S., Cheever, M. A. (1996) Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood 88, 202-210.
94. Madaio, M. P., Hodder, S., Schwartz, R. S., Stollar, B. D. (1984) Responsiveness of autoimmune and normal mice to nucleic acid antigens. J. Immunol. 132, 872-876.
95. Randolph, G. J., Beaulieu, S., Lebecque, S., Steinman, R. M., Muller, W. A. (1998) Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480-483.
96. Liu, H. M., Newbrough, S. E., Bhatia, S. K., Dahle, C. E., Krieg, A. M., Weiner, G. J. (1998) Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor. Blood 92, 3730-3736.
97. Xing, S., Waddell, J. E., Boynton, E. L. (2002) Changes in macrophage morphology and prolonged cell viability following exposure to polyethylene particulate in vitro. Microsc. Res. Tech. 57, 523-529.
98. Yui, S., Yamazaki, M. (1986) Induction of macrophage growth by effete cells. J. Leukoc. Biol. 39, 489-497.
99. Reddy, S. M., Hsiao, K. H., Abernethy, V. E., Fan, H., Longacre, A., Lieberthal, W., Rauch, J., Koh, J. S., Levine, J. S. (2002) Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation: activation of Akt and inhibition of extracellular signal-regulated kinases 1 and 2. J. Immunol. 169, 702-713.
100. Raff, M. C. (1992) Social controls on cell survival and cell death. Nature 356, 397-400.
101. Evan, G., Littlewood, T. (1998) A matter of life and cell death. Science 281, 1317-1322.
102. Bendelac, A., Medzhitov, R. (2002) Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J. Exp. Med. 195, F19-F23.
103. Kremer, L., Estaquier, J., Brandt, E., Ameisen, J. C., Locht C. (1997) Mycobacterium bovis Bacillus Calmette Guerin infection prevents apoptosis of resting human monocytes. Eur. J. Immunol. 27, 2450-2456.
104. Moore, K. J., Turco, S. J., Matlashewski, G. (1994) Leishmania donovani infection enhances macrophage viability in the absence of exogenous growth factor. J. Leukoc. Biol. 55, 91-98.
105. Heidenreich, S., Otte, B., Lang, D., Schmidt, M. (1996) Infection by Candida albicans inhibits apoptosis of human monocytes and monocytic U937 cells. J. Leukoc. Biol. 60, 737-743.
106. Bird, A. P. (1986) CpG-rich islands and the function of DNA methylation. Nature 321, 209-213.
107. Krieg, A. M., Yi, A. K., Matson, S., Wahlschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., Klinman, D. M. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
108. Lipford, G. B., Bauer, M., Blank, C., Reiter, R., Wagner, H., Heeg, K. (1997) CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur. J. Immunol. 27, 2340-2344.
109. Deng, G. M., Nilsson, I. M., Verdrengh, M., Collins, L. V., Tarkowski, A. (1999) Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5, 702-705.
110. Sester, D. P., Beasley, S. J., Sweet, M. J., Fowles, L. F., Cronau, S. L., Stacey, K. J., Hume, D. A. (1999) Bacterial/CpG DNA down-modulates colony stimulating factor-1 receptor surface expression on murine bone marrow-derived macrophages with concomitant growth arrest and factor-independent survival. J. Immunol. 163, 6541-6550.
111. Matzinger, P. (1994) Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045.
112. Matzinger, P. (2002) The danger model: a renewed sense of self. Science 296, 301-305.
113. Janeway Jr., C. A., Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
114. Zuany-Amorim, C., Hastewell, J., Walker, C. (2002) Toll-like receptors as potential therapeutic targets for multiple diseases. Nat. Rev. Drug Discov. 1, 797-807.
115. Libby, P., Ridker, P. M., Maseri, A. (2002) Inflammation and atherosclerosis. Circulation 105, 1135-1143.
116. Terkeltaub, R., Banka, C. L., Solan, J., Santoro, D., Brand, K., Curtiss, L. K. (1994) Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14, 47-53.
117. Chen, F., Sun, S. C., Kuh, D. C., Gaydos, L. J., Demers, L. M. (1995) Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages. Biochem. Biophys. Res. Commun. 214, 985-992.
118. Karin, M., Lin, A. (2002) NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227.
119. Beg, A. A. (2002) Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 23, 509-512.
120. Randolph, G. J., Sanchez-Schmitz, G., Liebman, R. M., Schakel, K. (2002) The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic. cells in a model tissue setting. J. Exp. Med. 196, 517-527.
121. Stanley, E. R., Berg, K. L., Einstein, D. B., Lee, P. S., Pixley, F. J., Wang, Y., Yeung, Y. G. (1997) Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46, 4-10.
122. Sawyer, R. T., Strausbauch, P. H., Volkman, A. (1982) Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab. Invest. 46, 165-170.